0001437749-18-001231.txt : 20180126 0001437749-18-001231.hdr.sgml : 20180126 20180126193101 ACCESSION NUMBER: 0001437749-18-001231 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180122 FILED AS OF DATE: 20180126 DATE AS OF CHANGE: 20180126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ASADORIAN RAFFI CENTRAL INDEX KEY: 0001628970 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 18553277 MAIL ADDRESS: STREET 1: TBD STREET 2: TBD CITY: TBD STATE: CA ZIP: 99999 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 rdgdoc.xml FORM 4 X0306 4 2018-01-22 0001427925 ACELRX PHARMACEUTICALS INC ACRX 0001628970 ASADORIAN RAFFI C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063 1 Chief Financial Officer Stock Option (Right to Buy) 2 2018-01-22 4 A 0 147500 0 A 2019-01-22 2028-01-21 Common Stock 147500 147500 D The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. Issued pursuant to the 2011 Equity Incentive Plan. /s/ Martha Adler, Attorney-in-fact 2018-01-26